More Than Lip Service: DEI in Private Equity
For the transaction between Shamrock Capital and AnswerLab, commitment to DEI took center stage
PE Weekly: Healthcare Niches Fuel M&A Activity
M&A targets healthcare from pediatrics to senior care to ophthalmology, while the public sector emerges as a strong acquisition target this week
Post-Closing M&A Claims and Purchase Price Adjustments: Where Do They Stand Heading Into 2023?
SRS Acquiom's Kip Wallen says dealmakers should prepare for an uptick in indemnification claims activity this year
Private Equity Leans Into the Flexibility of ESOPs
After decades of being overlooked, an ESOP evolution is making space for PE backers
PE Weekly: A Slew of New Funds
Several funds targeting middle-market businesses made their debut this week, while a flurry of M&A activity stretched across a variety of sectors
Without SAFE Banking Act’s Passage, What’s Next for Cannabis M&A?
Congress failed to pass the SAFE Banking Act in its lame-duck session. Burns & Levinson attorneys share what that means for dealmakers
No Uncertain Terms: Shifts in Key Deal Terms Ahead
Tightening lending conditions, stricter requirements for deal insurance and changes to key deal terms signal where the M&A market is headed in 2023
Lenders Sharpen Their Forecasting Tools
With storm clouds rolling into financial markets, debt providers are focusing on modeling downside scenarios for their portfolio companies
PE Weekly: Dealmakers Target Manufacturing and Industrials
Acquisitions and exits announced in energy, machinery, pharmaceuticals and more
3 Areas of Private Equity the SEC Is Watching in 2023
Recent SEC initiatives raise concerns for middle-market PE firms
